July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Short-term perfluoro-n-octane tamponade for complex retinal detachment
Author Affiliations & Notes
  • Shunji Kusaka
    Ophthalmology, Kindai University Sakai Hospital, Sakai, Osaka, Japan
  • Daishi Tsujioka
    Ophthalmology, Kindai University Sakai Hospital, Sakai, Osaka, Japan
  • Kazuki Kuniyoshi
    Ophthalmology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan
  • Koji Sugioka
    Ophthalmology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan
  • Yoshikazu Shimomura
    Ophthalmology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan
  • Footnotes
    Commercial Relationships   Shunji Kusaka, None; Daishi Tsujioka, None; Kazuki Kuniyoshi, None; Koji Sugioka, None; Yoshikazu Shimomura, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 4238. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shunji Kusaka, Daishi Tsujioka, Kazuki Kuniyoshi, Koji Sugioka, Yoshikazu Shimomura; Short-term perfluoro-n-octane tamponade for complex retinal detachment. Invest. Ophthalmol. Vis. Sci. 2018;59(9):4238.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The effectiveness of long-acting gas or silicone oil tamponade is limited when proliferative changes occur in the inferior retina or when patients are uncooperative with prone positioning. In such cases, we have been using short-term postoperative perfluoro-n-octane (PFO) tamponade. In this study, we evaluated the efficacy of this technique.

Methods : We conducted a chart review of 25 eyes of 24 patients [17 males and seven females; age range from 2.5 months to 75 years (median, 4.5 years)] with complex retinal detachment (RD) who underwent vitrectomy using this technique. The causes of RD were (eyes) retinopathy of prematurity (12), proliferative vitreoretinopathy (8), familial exudative vitreoretinopathy (3), and miscellaneous (2). The patients were followed for 6-64 months. Outcome measures included anatomical retinal status at the last visit and changes in best-corrected visual acuities (BCVAs) after surgery.

Results : PFO was removed 2 to 3 weeks after surgery in most cases. At the last visit, the retinas remained reattached in 20 of 25 eyes (80.0%). Pre- and postoperative BCVAs could be measured in four eyes. There was no statistical difference in pre- and postoperative BCVAs (P = 0.20, Mann–Whitney rank sum test). In one eye, emulcification of PFO was obeserved before PFO removal. No other apparent adverse events were noted in any eye.

Conclusions : Short-term postoperative PFO seems to be safe and effective in achieving anatomical success in eyes with complex RD.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×